Literature DB >> 24102947

Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses.

G Liao1, Y Wang, Y-Q Zhou, T-W Li, D-Q Zeng, X Zeng, J Li, H-X Dan, Q-M Chen.   

Abstract

BACKGROUND: A large number of meta-analyses and pooled analyses have been published on the topic of the genetic variants for oral cancer, and many positive results have been identified; however, there might be some false-positive results. The aim of this study was to identify the 'true positive' (noteworthy) results using the method of false-positive report probability (FPRP).
METHODS: The PubMed database, Embase database, CNKI database, and Wanfang database were searched to retrieve the meta-analyses, pooled analyses, and genome-wide association studies (GWAS), which addressed the associations between genetic polymorphisms and the risk of oral cancer. The significant associations were further analyzed using the method of FPRP.
RESULTS: A total of 14 variants were identified from meta-analyses and pooled analyses, which concern the associations between oral cancer and genetic variants. Among these 14 variants, 9 variants were reported to be significantly associated with the risk of oral cancer (CYP1A1-MspI, CYP2E1-RsaI/PstI, MTHFR-C677T, p73-G4C14-to-A4T14, XRCC1-Arg194Trp, CYP1A1-Ile462Val, GSTM1-±, and NAT2 slow vs rapid). After assessing the results of FPRP, none of the nine statistically significant associations were noteworthy (true positive). In addition, no noteworthy results were identified from GWAS.
CONCLUSIONS: In summary, this study found no noteworthy associations between variants and the risk of oral cancer. Further candidate genes associations studies should be performed to explore the etiology of oral cancer.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  false-positive report probability; genome-wide association studies; oral cancer; polymorphism

Mesh:

Year:  2013        PMID: 24102947     DOI: 10.1111/odi.12184

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  7 in total

1.  Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects.

Authors:  X I Yang; Yun Zhu; Dongxia Ye; Yang Liu; Hongying Sun; Min Ruan; Wei Liu
Journal:  Mol Clin Oncol       Date:  2016-04-20

2.  Positive association between MTHFR C677T polymorphism and oral cancer risk: a meta-analysis.

Authors:  Juan Jia; Zheng Ma; Shuangjiang Wu
Journal:  Tumour Biol       Date:  2014-02-01

3.  Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

Authors:  You-Cheng Lin; Xun Wu; Xue-Qiong Zhou; Rui Ren; Ze-Xuan Su; Chun-Xiao Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis.

Authors:  Sui Jiang; Jin-Dong Xu; Zhen-Jian Zhuo; Zhu-Ming Hua
Journal:  Onco Targets Ther       Date:  2017-01-10       Impact factor: 4.147

Review 5.  Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date.

Authors:  Krithiga Shridhar; Aastha Aggarwal; Gagandeep Kaur Walia; Smriti Gulati; A V Geetha; D Prabhakaran; Preet K Dhillon; Preetha Rajaraman
Journal:  Oral Oncol       Date:  2016-10       Impact factor: 5.337

6.  Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy.

Authors:  Chia-Min Chung; Chung-Chieh Hung; Chien-Hung Lee; Chi-Pin Lee; Ka-Wo Lee; Mu-Kuan Chen; Kun-Tu Yeh; Ying-Chin Ko
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

7.  N-acetyltransferase 2 polymorphisms and risk of esophageal cancer in a Chinese population.

Authors:  Liming Wang; Weifeng Tang; Suocheng Chen; Yangyong Sun; Yu Fan; Yijun Shi; Jingfeng Zhu; Xu Wang; Liang Zheng; Aizhong Shao; Guowen Ding; Chao Liu; Ruiping Liu; Jun Yin; Haiyong Gu
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.